Biomolecular markers of cancer-associated thromboembolism
- 31 October 2013
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 88 (1), 19-29
- https://doi.org/10.1016/j.critrevonc.2013.02.008
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Cancer and coagulationAmerican Journal of Hematology, 2012
- Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapyThrombosis Research, 2010
- Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismThrombosis Research, 2010
- Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivoThe Journal of Experimental Medicine, 2009
- C-reactive protein stimulates superoxide anion release and tissue factor activity in vivoAtherosclerosis, 2009
- Epidemiology of cancer-related venous thromboembolismBest Practice & Research Clinical Haematology, 2009
- Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patientsThrombosis Research, 2008
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJama-Journal Of The American Medical Association, 2008
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007